BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Stem cell
,
Avian flu virus
,
Doxorubicin
,
rs7903146
,
MYC
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tgfbr1 protein
Summary
General Info
Curated Studies
Most Correlated Studies
CD4+ T cells differentiated with alternate combinations of IL-1beta, IL-6 and TGFbeta
Point Mutation in TGFBR1 associated with regenerative healing - expression profiles
Embryonic fibroblasts treated with compounds targeting signaling pathways during iPSC formation
Intestinal organoids treated with Tgfb1 ligand or TgfbR1/2 inhibitor (LY2109761)
Fibroblasts treated with TGFbeta, IL1, EGF and small molecule inhibitors of TGFBR1 and p38
Explore Curated Studies Results
Literature
Most Relevant Literature
Tgfbr1 controls developmental plasticity between the hindlimb and external genitalia by remodeling t…
Shear-mediated ALK5 expression regulates endothelial activation.
Truncating variants in the penultimate exon of TGFBR1 escaping nonsense-mediated mRNA decay cause Lo…
ALK-5 Inhibitors for Efficient Derivation of Mesenchymal Stem Cells from Human Embryonic Stem Cells.
A novel nonsense mutation of TGFBR1 in a fetus with untypical Loeys-Dietz syndrome 1.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Extracellular Vesicles as Stroke Biomarkers
Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Be…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ